23.19
전일 마감가:
$23.50
열려 있는:
$23.45
하루 거래량:
148.75K
Relative Volume:
1.12
시가총액:
$269.24M
수익:
$7.49M
순이익/손실:
$-360.50M
주가수익비율:
-0.5612
EPS:
-41.3227
순현금흐름:
$-33.68M
1주 성능:
-6.94%
1개월 성능:
+6.52%
6개월 성능:
+25.42%
1년 성능:
+170.60%
Surrozen Inc Stock (SRZN) Company Profile
명칭
Surrozen Inc
전화
650-475-2820
주소
171 OYSTER POINT BLVD, SOUTH SAN FRANCISCO
Compare SRZN vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
SRZN
Surrozen Inc
|
23.19 | 269.24M | 7.49M | -360.50M | -33.68M | -41.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
|
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
|
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Surrozen Inc Stock (SRZN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-21 | 개시 | TD Cowen | Buy |
| 2026-02-19 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-01-30 | 개시 | H.C. Wainwright | Buy |
| 2025-01-03 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2021-10-11 | 개시 | BofA Securities | Buy |
| 2021-09-15 | 개시 | Guggenheim | Buy |
| 2021-09-07 | 개시 | Stifel | Buy |
모두보기
Surrozen Inc 주식(SRZN)의 최신 뉴스
Understanding Momentum Shifts in (SRZN) - Stock Traders Daily
Surrozen Inc Warrant 2026-01.08.31 on Surrozen Financial Disclosures & SEC Filings - TradingView
Price to sales forward of Surrozen, Inc. – NASDAQ:SRZN - TradingView
Price to book forward of Surrozen, Inc. – NASDAQ:SRZN - TradingView
Surrozen Inc. (SRZN) Holds Steady Near $25.79 as Biotech Sector Waits for CatalystHigh Reward Trades - dars.gov.et
Avoiding Lag: Real-Time Signals in (SRZN) Movement - Stock Traders Daily
Surrozen, Inc.(NasdaqCM: SRZN) added to Russell 2000 Index - marketscreener.com
Surrozen, Inc.(NasdaqCM: SRZN) added to Russell 2500 Growth Benchmark - marketscreener.com
Surrozen, Inc.(NasdaqCM: SRZN) dropped from Russell Microcap Value Benchmark Index - marketscreener.com
Surrozen, Inc.(NasdaqCM: SRZN) added to Russell 2000 Growth Benchmark - marketscreener.com
Surrozen, Inc.(NasdaqCM: SRZN) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Surrozen, Inc.(NasdaqCM: SRZN) added to Russell 3000 Index - marketscreener.com
Surrozen Inc Actuals & Estimates (NASDAQ:SRZN) - TradingView
SRZN Forecast — Price Target — Prediction for 2027 - TradingView
Price to book forward of Surrozen, Inc. – NASDAQ:SRZNW - TradingView
Enterprise value to EBIT forward of Surrozen, Inc. – NASDAQ:SRZNW - TradingView
Enterprise value to EBITDA forward of Surrozen, Inc. – NASDAQ:SRZNW - TradingView
Price to earnings forward of Surrozen, Inc. – NASDAQ:SRZNW - TradingView
Merck Swipes At Surrozen's IP Over Tissue Regrowth Proteins - Law360
Surrozen Inc (SRZNW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Surrozen Inc (SRZN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Surrozen Inc (SRZN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Discipline and Rules-Based Execution in SRZN Response - Stock Traders Daily
Surrozen Inc (SRZN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Surrozen (SRZN) Dips Over 3% as Stock Tests Key Support LevelsMA Crossover - dars.gov.et
Surrozen Inc (SRZN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Surrozen Inc (SRZN) Institutional Confidence - TradingKey
Surrozen Inc (SRZNW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Surrozen Inc (SRZNW) Institutional Confidence - TradingKey
Surrozen Inc (SRZNW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Surrozen Inc (SRZNW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Surrozen Inc (SRZNW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Surrozen Inc (SRZN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Surrozen Inc (SRZNW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Surrozen Inc (SRZNW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Surrozen Inc (SRZNW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
SRZN Q1 2026 Earnings: Massive EPS Miss Amid No RevenueEarnings Per Share - newsline.com
Surrozen Inc (SRZN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Surrozen Inc (SRZN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Surrozen Inc (SRZN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Surrozen (SRZN) CFO acquires 607 shares through 2021 employee stock purchase plan - Stock Titan
Surrozen (SRZN) EVP Li Yang gets 1,666 ESPP shares, now holds 18,882 - Stock Titan
Surrozen (SRZN) COO adds 1,666 shares through 2021 employee stock purchase plan - Stock Titan
Surrozen (SRZN) CEO awarded 1,622 ESPP shares at $8.11, now holds 18,175 - Stock Titan
SRZN Q1 2026 Earnings: Significant EPS Miss Reflects Operational ChallengesPeak Earnings Alert - newsline.com
Surrozen Inc. (SRZN) Q1 2026 Earnings: Significant EPS Miss Amidst Operational UpdatesEarnings Whisper Number - newsline.com
Surrozen Warrants (SRZNW) Hold Steady at $0.02 Amidst Minimal MovementCovered Call ETF - newsline.com
SRZN Q1 2026 Earnings: Significant EPS Miss Amid Sharp Stock RallyGeographic Revenue Trends - newsline.com
Surrozen Warrant (SRZNW) Holds at $0.02 as Trading Action Remains MutedUnusual Call Volume - newsline.com
Surrozen Inc. Warrant (SRZNW) Stabilizes at $0.02 Amid Minimal Trading ActivityPrice Surge Stocks - newsline.com
Surrozen Inc. Warrant (SRZNW): Price Stability at $0.02 Amid Minimal TradingNaked POC - newsline.com
Surrozen Inc (SRZN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Surrozen Inc 주식 (SRZN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Williams Charles O | Chief Operating Officer |
May 04 '26 |
Sale |
33.33 |
2,036 |
67,866 |
16,571 |
| Parker Craig C | Chief Executive Officer |
May 04 '26 |
Sale |
33.33 |
4,524 |
150,798 |
16,553 |
| TCG Crossover GP II, LLC | 10% Owner |
Mar 24 '26 |
Buy |
24.69 |
106,658 |
2,633,717 |
736,554 |
| TCG Crossover GP II, LLC | 10% Owner |
Mar 23 '26 |
Buy |
24.90 |
15,223 |
379,051 |
683,225 |
| TCG Crossover GP II, LLC | 10% Owner |
Mar 13 '26 |
Buy |
24.88 |
35,433 |
881,463 |
675,018 |
| TCG Crossover GP II, LLC | 10% Owner |
Mar 12 '26 |
Buy |
24.99 |
12,374 |
309,166 |
657,301 |
| TCG Crossover GP II, LLC | 10% Owner |
Mar 16 '26 |
Buy |
24.99 |
1,190 |
29,733 |
675,613 |
| TCG Crossover GP II, LLC | 10% Owner |
Feb 11 '26 |
Buy |
23.57 |
17,763 |
418,763 |
650,567 |
| TCG Crossover GP II, LLC | 10% Owner |
Feb 12 '26 |
Buy |
23.86 |
1,093 |
26,082 |
651,114 |
| TCG Crossover GP II, LLC | 10% Owner |
Feb 03 '26 |
Buy |
21.94 |
4,355 |
95,549 |
641,685 |
자본화:
|
볼륨(24시간):